Bioscience & Pharmaceutical

Synnovation Therapeutics, a precision oncology company established by former Incyte researchers, has received state taxpayer-backed grants to help fuel the next stage of growth at DuPont’s Experimental Station.

The 41,000 square-foot STEM Hub will serve as an education, workforce development and community center for the riverside of Wilmington.

WILMINGTON — Incyte has announced promising results from a third phase of a trial studying Monjuvi, including...

DOVER – A new pharmaceutical and supplement company is headed for Kent County this holiday season and...

WILMINGTON — Clinical trials at Prelude Therapeutics have made significant headway with Phase 1 results of one...

Scores of people gathered at the Hotel du Pont to celebrate Incyte as the honoree of the Pete du Pont Foundation Freedom award Tuesday night.

The new Director of University and Industry Relations, Life Sciences believes her role is to serve as a voice for the biotech industry and university.

DOVER — Wilmington University is paving the way for an improved workforce within the scientific community with...

NEWARK — A room full of women in STEM fields gathered on Thursday, Sept. 26 at Deerfield...

Niktimvo is approved for treatment of chronic graft-versus-host disease. Incyte and its partner developer forecast that it may earn $650 million in net profit.